Volume 24, Number 9—September 2018
Synopsis
Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers
Figure 3

Figure 3. Flowchart of healthcare workers exposed to patients infected with Crimean-Congo hemorrhagic fever virus who did and did not receive PEP with ribavirin or early ribavirin treatment <48 hours after symptom onset, 1976–2017. *Healthcare workers for which PEP information was not included in the original report. PEP, postexposure prophylaxis.
Page created: August 14, 2018
Page updated: August 14, 2018
Page reviewed: August 14, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.